-
Idifarma Expands High Potent Capabilities
Idifarma has launched new GMP spray drying capabilities. The new capabilities will allow the contract development and manufacturing organizations (CDM...
2018-03-30 17:02 -
Actinium, Astellas Form Research Partnership
Actinium Pharmaceuticals has entered into a research and option agreement with Astellas to develop Actinium-225 Radio-Conjugates (ARCs) using its Acti...
2018-03-30 17:02 -
Gyros Protein Technologies Upgrades Services
Gyros Protein Technologies AB, a provider of automated nanoliter-scale immunoassays and peptide synthesizers and reagents, said Oxford BioMedica, a ge...
2018-03-30 16:58 -
EU Ready To Review Shire’s Lanadelumab For HAE
EU regulators have validated Shire’s application to market its experimental hereditary angioedema (HAE) drug lanadelumab, indicating that there is su...
2018-03-30 16:50 -
Martin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™
Martin Pharmaceuticals, a clinical stage pharmaceutical company focused on repurposing already-approved drugs to offer life-changing advances to patie...
2018-03-30 16:50 -
Nabriva, Roivant Collaborate For China Rights To Novel Antibiotic
Nabriva Therapeutics, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serio...
2018-03-30 16:50 -
Study Changes Long-Held Concepts Of Cell Decoding
Scientists at the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) have uncovered evidence that shows a more complex and elab...
2018-03-29 18:00 -
Merck As The Best Bioprocessing Supplier In Asia
Merck, a leading science and technology company, was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessin...
2018-03-29 17:53 -
FDA Gives Mylan’s New HIV Drug a Thumbs-Up
The U.S. Food and Drug Administration (FDA) approved Mylan NV’s Symfi (efavirnenz, lamivudine and tenofovir disoproxil fumarate) for adult and pediat...
2018-03-29 17:53 -
GSK to Pay $13B for Novartis’ Stake in Consumer Healthcare JV
GlaxoSmithKline (GSK) has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint Venture for $...
2018-03-29 14:40
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- Europe’s Chemical Industry So... Jan 21, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
Related Products
Related Producers
